← Leaderboards
Boris Reidel
Univ Of North Carolina Chapel Hill
$583,125
Attributed
$583,125
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $233.3K · FY2018–23$250K$187.5K$125K$62.5K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$583,125 · 2
By mechanism
R21$427,625 · 1
R03$155,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Michael Rubinstein$1,930,820
- Brian M Button$7,838,604
- Bernard E. Weissman$16,032,468
- Mehmet Kesimer$11,256,253
- Alessandra Maria Livraghi-Butrico$1,549,450
Others in their field
Other Emerging Leaders on “Modification”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Mark Marino · Venturewell$49,647,567
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$31,778,457
Research focus
ModificationMucous Body SubstanceHydration StatusInnate Immune ResponseMeasurementLungCigarette SmokingFutureImpairmentInflammationLiquid SubstanceIn VitroBiological MarkersAldehydesAntimicrobial2-ButenalAdductExposure ToChronicAcetaldehydeCigaretteCigarette SmokeAcroleinNasal Epithelium
Grant awards (4)
Airway Biomarker Based Assessment of Combusted to Non-Combusted Tobacco Use Transition Effects$233,250
R21 · FY2023 · HL · contact PI
Airway Biomarker Based Assessment of Combusted to Non-Combusted Tobacco Use Transition Effects$194,375
R21 · FY2022 · HL · contact PI
Airway Protein Modifications caused by New and Emerging Tobacco Products as Markers of Exposure and Potential Health Risks$77,750
R03 · FY2019 · HL · contact PI
Airway Protein Modifications caused by New and Emerging Tobacco Products as Markers of Exposure and Potential Health Risks$77,750
R03 · FY2018 · HL · contact PI